Medicine and Dentistry
Decision Making
100%
Breast Cancer
100%
Adjuvant Chemotherapy
100%
Recurrence Risk
100%
Relative Risk Reduction
100%
Medical Student
50%
Postmenopause
50%
Hormone Receptor
50%
Lymph Node
50%
Tamoxifen
50%
Risk Reduction
50%
Numbers Needed to Treat
50%
Keyphrases
Breast Cancer
100%
Chemotherapy
100%
Adjuvant Chemotherapy
100%
Recurrence Risk
100%
Risk Influence
100%
Survival Benefit
75%
Treatment Decisions
25%
Relative Risk Reduction
25%
Postmenopausal Women
12%
Lymph Node Positive
12%
Absolute Risk Reduction
12%
Patient Benefit
12%
Risk Information
12%
Hormone Receptor-positive Breast Cancer
12%
Number-needed-to-treat
12%
Preclinical Medical Students
12%
Decision Participant
12%
Nursing and Health Professions
Breast Cancer
100%
Adjuvant Chemotherapy
100%
Recurrence Risk
100%
Medical Student
50%
Hormone Receptor
50%
Tamoxifen
50%
Numbers Needed to Treat
50%
Neuroscience
Decision-Making
100%
Hormone Receptor
100%
Lymph Node
100%
Tamoxifen
100%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Breast Cancer
100%
Recurrence Risk
100%
Hormone Receptor
11%
Tamoxifen
11%
Number Needed to Treat
11%